NGF antagonist pain therapy using the low-affinity p75 neurotrophic factor receptor extracellular domain fused with the Fc portion.

JP2026517425APending Publication Date: 2026-05-29LEVICEPT LTD
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
LEVICEPT LTD
Filing Date
2024-05-21
Publication Date
2026-05-29

Smart Images

  • Figure 2026517425000001
    Figure 2026517425000001
  • Figure 2026517425000002
    Figure 2026517425000002
  • Figure 2026517425000003
    Figure 2026517425000003
Patent Text Reader

Abstract

The present invention relates to a p75NTR neurotrophic factor-binding protein (NBP)-Fc fusion protein comprising a p75NTR(NBP) moiety and an immunoglobulin moiety. In one embodiment, the p75NTR(NBP)-Fc fusion protein is intended for use in the treatment of pain and / or symptoms of pain.
Need to check novelty before this filing date? Find Prior Art